Abbott Laboratories Receives FDA Clearance and CE Mark for Ultreon™ 3.0 Software
Abbott Laboratories (ABT) received U.S. Food and Drug Administration clearance and a CE Mark for its next-generation AI-powered Ultreon™ 3.0 imaging platform, which is designed to enhance coronary procedures by integrating real-time data with automated insights.
Tickers: $ABT
Topics: AI CE_Mark FDA_clearance medical_devices